A new member of the immunoglobulin superfamily—CTLA-4

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  1987-07-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/328267A0PMID 3496540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A system of nomenclature for band patterns of mouse chromosomes

  2004cited by this paper
• Interactions between MHC-encoded products and cloned T-cells. I. Fine specificity of induction of proliferation and lysis

  2004cited by this paper
• DNA probe localization at 18p113 band by in situ hybridization and identification of a small supernumerary chromosome

  2004cited by this paper
• Genetic and functional relationships of the retroviral and lymphocyte alloantigen loci on mouse Chromosome 1

  2004cited by this paper
• A complementary DNA clone for a macrophage-lymphocyte Fc receptor

  1986cited by this paper
• Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

  1986cited by this paper
• Phosphatidylinositol is involved in the membrane attachment of NCAM‐120, the smallest component of the neural cell adhesion molecule.

  1986cited by this paper
• Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors.

  1986cited by this paper
• The growing immunoglobulin gene superfamily.

  1986cited by this paper
• Isolation and sequence of L3T4 complementary DNA clones: expression in T cells and brain.

  1986cited by this paper
• Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte.

  1986cited by this paper
• Novel serine proteases encoded by two cytotoxic T lymphocyte-specific genes.

  1986cited by this paper
• Striking similarities between antigen receptor J pieces and sequence in the second chain of the murine CD8 antigen

  1986cited by this paper
• The inducible cytotoxic T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization to mouse chromosome 14

  1986cited by this paper
• Alleles of the Ly-17 alloantigen define polymorphisms of the murine IgG Fc receptor.

  1985cited by this paper
• Analysis of the Thy‐1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy‐1 epitopes

  1985cited by this paper
• Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions.

  1985cited by this paper
• The mouse Ly-17 locus identifies a polymorphism of the Fc receptor

  1985cited by this paper
• Diversity and structure of genes of the alpha family of mouse T-cell antigen receptor.

  1985cited by this paper
• A glycophospholipid tail at the carboxyl terminus of the Thy-1 glycoprotein of neurons and thymocytes.

  1985cited by this paper
• T cell antigen receptors and the immunoglobulin supergene family.

  1985cited by this paper
• The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains

  1984cited by this paper
• A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes

  1984cited by this paper
• Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid

  1984cited by this paper
• Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins

  1984cited by this paper
• The isolation of a human Ig V lambda gene from a recombinant library of chromosome 22 and estimation of its copy number.

  1984cited by this paper
• Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

  1984cited by this paper
• An extra segment in chromosome 1 of wild Mus musculus: a C-band positive homogeneously staining region.

  1984cited by this paper
• A simple and very efficient method for generating cDNA libraries.

  1983cited by this paper
• Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

  1983cited by this paper
• Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin.

  1982cited by this paper
• A simple method for displaying the hydropathic character of a protein.

  1982cited by this paper
• Establishment of B cell hybridomas with B cell surface antigens.

  1982cited by this paper
• Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity

  1982cited by this paper
• The erythrocyte anion transport protein is contranslationally inserted into microsomes.

  1982cited by this paper
• Characterization of an Lyt‐l+ Cytolytic T‐Cell Clone Specific for a Polymorphic Domain of the I‐Ak Molecule

  1982cited by this paper
• Patterns of DNA replication of human chromosomes. II. Replication map and replication model.

  1982cited by this paper
• Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.

  1981cited by this paper
• A new method for sequencing DNA.

  1977cited by this paper
• REJECTION OF ASCITES TUMOR ALLOGRAFTS

  1972cited by this paper

• Digestive System Toxicities of Immune Checkpoint Inhibitors: Mechanisms and Clinical Implications

  2026cites this paper
• Next-generation cancer therapies: translating experimental advances into clinical practice.

  2026cites this paper
• Advances in Cancer Immunotherapy Regulators of Immune Checkpoints and Effects on the Heart

  2026cites this paper
• Clathrin mediated endocytosis targeting chimera for targeted membrane proteins degradation and enhance CAR-T cell anti-tumor therapy

  2026cites this paper
• Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

  2026cites this paper
• Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion

  2026cites this paper
• The role of immune checkpoint molecules in cancers

  2026cites this paper
• Autoimmunity in the era of immune checkpoint inhibitors: the evolving epidemiology of autoimmune diseases and the possible impact of COVID-19.

  2026cites this paper
• T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities.

  2026cites this paper
• Nanomedicine-driven strategies for CD8+ T cell enhancement in Cancer immunotherapy

  2026cites this paper
• Influence of the tumor microenvironment on genetic mutations in thyroid carcinoma

  2026cites this paper
• The role of coinhibitory receptor-expressing non-T cells in inflammation and immunity: unsung heroes or peripheral players?

  2025cites this paper
• Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000–2025)

  2025cites this paper
• Tumor immunotherapy: past, present, and future

  2025cites this paper
• Emerging therapies in Multiple Myeloma: Leveraging immune checkpoint inhibitors for improved outcomes

  2025cites this paper
• Regulatory T cells in renal cell carcinoma: tumor-promoting mechanisms and emerging therapeutic strategies.

  2025cites this paper
• Comprehensive analysis of genomic alterations and novel prognostic biomarkers, and establishment of prediction models of metastasis in metastatic non-small cell lung cancer

  2025cites this paper
• Advances in tumor micro-environment and immunotherapy of squamous cell carcinoma of the tongue.

  2025cites this paper
• Exploring immune checkpoint inhibitors: Focus on PD-1/PD-L1 axis and beyond.

  2025cites this paper
• Nano drug delivery systems for advanced immune checkpoint blockade therapy

  2025cites this paper
• The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure

  2025cites this paper
• Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy.

  2025cites this paper
• HLA Class I and II genes: A key factor for type one diabetes susceptibility

  2025cites this paper
• [From 1985 to 2025, the Glorious Forty years of immunology and… medicine/sciences: From fundamental immunology to the immunotherapy revolution].

  2025cites this paper
• PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy

  2025cites this paper
• Cancer immunotherapy in progress—an overview of the past 130 years

  2025cites this paper
• Expanding the immunotherapy universe in extensive-stage small cell lung cancer: from chemoimmunotherapy backbone to next-wave combinations

  2025cites this paper
• Combined Immunotherapy in Treating Patients with Advanced Hepatocellular Carcinoma

  2025cites this paper
• Detection of tumor immune checkpoints: from pathological analysis to functional imaging

  2025cites this paper
• Current Advances and Future Directions of Combined ICIs and TILs in Solid Tumors.

  2025cites this paper
• CTLA-4—two pathways to anti-tumour immunity?

  2025cites this paper
• Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors

  2025cites this paper
• Cytotoxic lycorine alkaloids of the plant family Amaryllidaceae.

  2025cites this paper
• CD28 Superfamily Costimulatory Molecules in Chronic Pain: Focus on Immunomodulation

  2025cites this paper
• The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer

  2025cites this paper
• The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy.

  2025cites this paper
• Application of Immune Checkpoint Inhibitors in Cancer

  2025cites this paper
• Impact of Impaired Renal Function on the Efficacy and Safety of Second‐Line Tyrosine Kinase Inhibitor Therapy After First‐Line Immuno‐Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study

  2025cites this paper
• Decoding the Tumor Microenvironment: Insights and New Targets from Single-Cell Sequencing and Spatial Transcriptomics

  2025cites this paper
• Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy

  2025cites this paper
• Therapeutic potential of triple-negative breast cancer immune checkpoint blockers: A 21-year bibliometric analysis

  2025cites this paper
• Alternative Splicing: A Key Regulator in T cell Response and Cancer Immunotherapy.

  2025cites this paper
• Immunotherapy for precision medicine in colorectal cancer

  2025cites this paper
• Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial

  2025cites this paper
• Exosome: The hidden messengers in cancer detection and immunotherapy.

  2025cites this paper
• Mapping a New Blueprint of Multimodal Immunotherapy Against Prostate Cancer: Breakthroughs, Barriers, and Bold Frontiers

  2025cites this paper
• Roles of Cellular Neighborhoods in Hepatocellular Carcinoma Pathogenesis.

  2025cites this paper
• Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

  2025cites this paper
• Immunotherapy-Related Hypophysitis: A Narrative Review

  2025cites this paper
• Six events that shaped antibody approvals in oncology

  2025cites this paper
• Concomitant medication effects on patients with lung cancer taking immune checkpoint inhibitors a review

  2025cites this paper
• Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review

  2025cites this paper
• Host directed immunotherapy for chronic infections and cancer.

  2025cites this paper
• Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020–2024)

  2025cites this paper
• Negative Immune Checkpoint Inhibitors

  2025cites this paper
• Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

  2025cites this paper
• Extraordinary diversity of the CD28/CTLA4 family across jawed vertebrates

  2024cites this paper
• Immunotherapy in Oral Cancer

  2024cites this paper
• Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators

  2024cites this paper
• Emerging innovative treatment strategies for advanced clear cell renal cell carcinoma

  2024cites this paper
• A comprehensive review of immune checkpoint inhibitors for cancer treatment.

  2024cites this paper
• Immune Checkpoints and Graves' Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review

  2024cites this paper
• Coley’s Toxin to First Approved Therapeutic Vaccine—A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment

  2024cites this paper
• Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer.

  2024cites this paper
• Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy

  2024cites this paper
• Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape

  2024cites this paper
• Resident memory T cells and cancer.

  2024cites this paper
• Inborn Errors of Immunity and Cytokine Storm Syndromes.

  2024cites this paper
• The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy.

  2024cites this paper
• Current Advances in Immunotherapy for Cancer

  2024cites this paper
• Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

  2024cites this paper
• CD28 co-stimulation: novel insights and applications in cancer immunotherapy

  2024cites this paper
• Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?

  2024cites this paper
• T cell dysfunction and therapeutic intervention in cancer

  2024cites this paper
• Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers.

  2024cites this paper
• Cluster of differentiation molecules in the metabolic syndrome.

  2024cites this paper
• Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model

  2024cites this paper
• Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy

  2024cites this paper
• Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

  2024cites this paper
• Legacy of the discovery of the T-cell receptor: 40 years of shaping basic immunology and translational work to develop novel therapies

  2024cites this paper
• Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies

  2024cites this paper
• Immunotherapy guided precision medicine in solid tumors.

  2024cites this paper
• Tumor biomarkers for diagnosis, prognosis and targeted therapy

  2024cites this paper
• Emerging trends and therapeutic applications of monoclonal antibodies.

  2024cites this paper
• Alginate-Chitosan Biodegradable and Biocompatible Based Hydrogel for Breast Cancer Immunotherapy and Diagnosis: A Comprehensive Review

  2024cites this paper
• A novel doxorubicin/CTLA-4 blocker co-loaded drug delivery system improves efficacy and safety in antitumor therapy

  2024cites this paper
• Influence of Microbiota on Tumor Immunotherapy

  2024cites this paper
• Immunologic tumor microenvironment modulators for turning cold tumors hot

  2024cites this paper
• Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient.

  2024cites this paper
• Immune Checkpoint Inhibitors and Male Fertility: Should Fertility Preservation Options Be Considered before Treatment?

  2024cites this paper
• Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance.

  2024cites this paper
• Mechanistic Insights into the Inhibition of a Common CTLA-4 Gene Mutation in the Cytoplasmic Domain

  2024cites this paper
• Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors.

  2024cites this paper
• Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer

  2024influential citation
• Effect of CTLA-4 Inhibition on Inflammation and Apoptosis After Spinal Cord Injury

  2024cites this paper
• Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma.

  2024cites this paper
• Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision

  2024cites this paper
• Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets.

  2024cites this paper
• Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases

  2024cites this paper
• Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy

  2024cites this paper